47% of pharma MOUs from VGGS 2024 commissioned

Gandhinagar:  The state govt said that 47% of MoUs signed in the pharmaceutical sector in the Vibrant Gujarat Global Summit (VGGS) 2024 have been commissioned. It said on Friday that of the 370 MoUs signed in the sector in the last summit held in January 2024, 175 were commissioned and 153 are in various stages of implementation.

The MoUs signed in the pharma sector had resulted in a total investment of approximately Rs 11,114.13 crore, providing employment to 20,141 people in the state, health minister Rushikesh Patel said. Pharmaceutical companies had pledged Rs 30,000 crore in investments during VGGS 2024.

An official statement said that among the commissioned projects in 2024, foreign companies like Senador Laboratories Pvt Ltd, Spain, invested Rs 2,500 crore in contraceptive drug production, creating 500 jobs. Amneal Pharmaceutical Pvt Ltd, US, invested Rs 700 crore in injectable drug production, also creating 500 jobs. Sysmex India Pvt Ltd, in collaboration with Japan, invested Rs 210 crore in medical device production, providing employment to 70 people.

Merrill Group invested Rs 910 crore in medical device production, creating 300 jobs, while Swati Spentose Pvt Ltd, Vapi, invested Rs 500 crore, providing employment to 300 people.

Related Posts

Licences of 20 medical stores suspended after inspections

Drug Control Department inspects 120 medical stores; 32 NDPS cases and 63 arrests recorded in 2026 so far The district administration has intensified action against illegal drug sale and distribution,…

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

NEW DELHI: Global investment firm Bain Capital has divested nearly a 1 per cent stake in Emcure Pharmaceuticals for over Rs 289 crore through open market transactions, according to the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert

Civil society group SAM calls for greater transparency involving clinical trials

Civil society group SAM calls for greater transparency involving clinical trials

Different packaging, typos expose fake Mounjaro racket

Different packaging, typos expose fake Mounjaro racket